Prenetics Global Limited Class A Ordinary Share PRE

$22.97 +0.04 (0.17%)

Valuation

Market cap
387,596,000
Revenue TTM
$92,390,000
Net income TTM
$-37,710,000
PE ratio
0.00
Forward PE
—
Profit margin
-40.82%
Debt to equity
0.00

Trading

Volume
136,800
Avg volume
220,658
Day's range
$22.22 – $23.68
Shares out
16,874,000
Stochastic %K
41%
Beta
0.31
Analysts
Strong Sell
Price target
$35.86

Price

Company profile

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headq...

Show more

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Industry
Packaged Foods
Sector
Consumer Defensive
Phone
852 2210 9588
Website
https://www.prenetics.com
Address
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong

Latest news

No headlines yet.